Scott Schell

Scott Schell serves as the Chief Medical Officer at Cognizant, where responsibilities include leading clinical and technology initiatives to enhance healthcare and life sciences strategy. Prior experience includes serving as Chief Executive Officer at Innovatim, Inc., focusing on strategic consulting for startups, M&A, and market entry across various sectors, including manufacturing and pharmaceuticals. Scott also held the positions of Chief Medical Officer and Venture Partner at Aspire Universal, overseeing a precision medicine portfolio, and Executive Consultant and Managing Director at UPMC, where a significant population health management technology platform was redesigned under Scott's leadership. Additionally, as President and Chief Executive Officer of KEW Group Inc., Scott managed a turnaround for a molecular diagnostics company. Academic qualifications include a Master's in Business Administration from the University of Michigan and residency and fellowship training in Surgery and Surgical Oncology from The Johns Hopkins University School of Medicine.